Full Text
The Full Text of this article is available as a PDF (40.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bellamy N., Kirwan J., Boers M., Brooks P., Strand V., Tugwell P., Altman R., Brandt K., Dougados M., Lequesne M. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol. 1997 Apr;24(4):799–802. [PubMed] [Google Scholar]
- Berkanovic E., Hurwicz M. L., Lachenbruch P. A. Concordant and discrepant views of patients' physical functioning. Arthritis Care Res. 1995 Jun;8(2):94–101. doi: 10.1002/art.1790080207. [DOI] [PubMed] [Google Scholar]
- Criswell L. A., Henke C. J. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis? J Rheumatol. 1995 May;22(5):829–835. [PubMed] [Google Scholar]
- Jordan K. M., Arden N. K., Doherty M., Bannwarth B., Bijlsma J. W. J., Dieppe P., Gunther K., Hauselmann H., Herrero-Beaumont G., Kaklamanis P. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003 Dec;62(12):1145–1155. doi: 10.1136/ard.2003.011742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirwan John, Heiberg Turid, Hewlett Sarah, Hughes Rod, Kvien Tore, Ahlmèn Monica, Boers Maarten, Minnock Patricia, Saag Kenneth, Shea Beverley. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol. 2003 Apr;30(4):868–872. [PubMed] [Google Scholar]
- Saag Kenneth G. OMERACT 6 brings new perspectives to rheumatology measurement research. J Rheumatol. 2003 Apr;30(4):639–641. [PubMed] [Google Scholar]
- Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., Bombardier C., Felson D., Hochberg M., van der Heijde D. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2004 Jun 18;64(1):29–33. doi: 10.1136/ard.2004.022905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., Bombardier C., Felson D., Hochberg M., van der Heijde D. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis. 2004 May 6;64(1):34–37. doi: 10.1136/ard.2004.023028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Gestel A. M., Prevoo M. L., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996 Jan;39(1):34–40. doi: 10.1002/art.1780390105. [DOI] [PubMed] [Google Scholar]